2-73490794-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001378454.1(ALMS1):​c.8835C>G​(p.Asn2945Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0119 in 1,614,052 control chromosomes in the GnomAD database, including 159 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N2945D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0079 ( 5 hom., cov: 32)
Exomes 𝑓: 0.012 ( 154 hom. )

Consequence

ALMS1
NM_001378454.1 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.661

Publications

12 publications found
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
ALMS1 Gene-Disease associations (from GenCC):
  • Alstrom syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038140416).
BP6
Variant 2-73490794-C-G is Benign according to our data. Variant chr2-73490794-C-G is described in ClinVar as Benign. ClinVar VariationId is 221010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00793 (1208/152280) while in subpopulation NFE AF = 0.0129 (875/68022). AF 95% confidence interval is 0.0122. There are 5 homozygotes in GnomAd4. There are 538 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALMS1NM_001378454.1 linkc.8835C>G p.Asn2945Lys missense_variant Exon 10 of 23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkc.8835C>G p.Asn2945Lys missense_variant Exon 10 of 23 NP_055935.4 Q8TCU4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkc.8835C>G p.Asn2945Lys missense_variant Exon 10 of 23 1 NM_001378454.1 ENSP00000482968.1 Q8TCU4-1

Frequencies

GnomAD3 genomes
AF:
0.00796
AC:
1211
AN:
152162
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00285
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00399
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00663
Gnomad FIN
AF:
0.00924
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0129
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00876
AC:
2185
AN:
249400
AF XY:
0.00895
show subpopulations
Gnomad AFR exome
AF:
0.00420
Gnomad AMR exome
AF:
0.00183
Gnomad ASJ exome
AF:
0.00735
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00844
Gnomad NFE exome
AF:
0.0139
Gnomad OTH exome
AF:
0.00760
GnomAD4 exome
AF:
0.0123
AC:
17945
AN:
1461772
Hom.:
154
Cov.:
33
AF XY:
0.0122
AC XY:
8849
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.00224
AC:
75
AN:
33480
American (AMR)
AF:
0.00186
AC:
83
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00628
AC:
164
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.00546
AC:
471
AN:
86256
European-Finnish (FIN)
AF:
0.00955
AC:
509
AN:
53324
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0145
AC:
16153
AN:
1111992
Other (OTH)
AF:
0.00798
AC:
482
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1170
2340
3511
4681
5851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00793
AC:
1208
AN:
152280
Hom.:
5
Cov.:
32
AF XY:
0.00722
AC XY:
538
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00284
AC:
118
AN:
41568
American (AMR)
AF:
0.00399
AC:
61
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00601
AC:
29
AN:
4822
European-Finnish (FIN)
AF:
0.00924
AC:
98
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0129
AC:
875
AN:
68022
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
64
127
191
254
318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0115
Hom.:
14
Bravo
AF:
0.00711
TwinsUK
AF:
0.0146
AC:
54
ALSPAC
AF:
0.0161
AC:
62
ESP6500AA
AF:
0.00372
AC:
14
ESP6500EA
AF:
0.0144
AC:
118
ExAC
AF:
0.00963
AC:
1164
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.0111
EpiControl
AF:
0.0114

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 21, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16720663, 25296579, 17594715) -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ALMS1: BP4, BS1, BS2 -

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Asn2944Lys in exon 10 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 1.38% (921/66738) of European chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs35062203). -

Alstrom syndrome Benign:2
Oct 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Monogenic diabetes Benign:1
Feb 22, 2019
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG criteria: BP4 (9 predictors; Revel score 0.007), BS2 (18 homozygotes in gnomAD), BP1 (missense in gene with truncating mutations), BA1 (1.4% in European gnomAD; 1.1% in ESP); [InVitae, Partners & Childrens Mercy say benign but no longer using BP6]= benign -

Cardiovascular phenotype Benign:1
Dec 29, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.89
DANN
Benign
0.73
DEOGEN2
Benign
0.028
T;.;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.035
N
LIST_S2
Benign
0.49
T;T;T
MetaRNN
Benign
0.0038
T;T;T
MetaSVM
Benign
-0.93
T
PhyloP100
-0.66
PrimateAI
Benign
0.35
T
Sift4G
Benign
0.25
T;T;T
Vest4
0.11
MVP
0.072
ClinPred
0.000034
T
GERP RS
-0.22
Varity_R
0.025
gMVP
0.0077
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35062203; hg19: chr2-73717921; COSMIC: COSV99064702; API